Lacaita, P.G.; Bilgeri, V.; Barbieri, F.; Scharll, Y.; Dichtl, W.; Widmann, G.; Feuchtner, G.M.
Lipomatous Hypertrophy of the Interatrial Septum (LHIS) a Biomarker for Cardiovascular Protection? A Hypothesis Generating Case–Control Study. J. Cardiovasc. Dev. Dis. 2025, 12, 301.
https://doi.org/10.3390/jcdd12080301
AMA Style
Lacaita PG, Bilgeri V, Barbieri F, Scharll Y, Dichtl W, Widmann G, Feuchtner GM.
Lipomatous Hypertrophy of the Interatrial Septum (LHIS) a Biomarker for Cardiovascular Protection? A Hypothesis Generating Case–Control Study. Journal of Cardiovascular Development and Disease. 2025; 12(8):301.
https://doi.org/10.3390/jcdd12080301
Chicago/Turabian Style
Lacaita, Pietro G., Valentin Bilgeri, Fabian Barbieri, Yannick Scharll, Wolfgang Dichtl, Gerlig Widmann, and Gudrun M. Feuchtner.
2025. "Lipomatous Hypertrophy of the Interatrial Septum (LHIS) a Biomarker for Cardiovascular Protection? A Hypothesis Generating Case–Control Study" Journal of Cardiovascular Development and Disease 12, no. 8: 301.
https://doi.org/10.3390/jcdd12080301
APA Style
Lacaita, P. G., Bilgeri, V., Barbieri, F., Scharll, Y., Dichtl, W., Widmann, G., & Feuchtner, G. M.
(2025). Lipomatous Hypertrophy of the Interatrial Septum (LHIS) a Biomarker for Cardiovascular Protection? A Hypothesis Generating Case–Control Study. Journal of Cardiovascular Development and Disease, 12(8), 301.
https://doi.org/10.3390/jcdd12080301
